Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Wakelam

Showing results (121-130 of 129) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 129 results.
Advances in Enzyme Regulation|January 1, 1997
Role and regulation of phospholipase D activity in normal and cancer cellsM J Wakelam, A Martin, M N Hodgkin, et al.
Biochemical Society Transactions|November 1, 1993
Phosphatidylcholine hydrolysis: a source of multiple lipid messenger moleculesM J Wakelam, C P Briscoe, A Stewart, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1996
Antigen receptors on immature, but not mature, B and T cells are coupled to cytosolic phospholipase A2 activation: expression and activation of cytosolic phospholipase A2 correlate with lymphocyte maturationJ J Gilbert, A Stewart, C A Courtney, et al.
Advances in Second Messenger and Phosphoprotein Research|January 1, 1993
Phosphatidylcholine hydrolysis: a multiple messenger generating systemM J Wakelam, T R Pettitt, P Kaur, et al.
Biochimica Et Biophysica Acta|January 20, 1998
Inhibition of phospholipid signalling and proliferation of Swiss 3T3 cells by the wortmannin analogue demethoxyviridinM J Cross, M N Hodgkin, J A Plumb, et al.
British Journal of Cancer|March 22, 2012
Serum matrix metalloproteinase 9 and colorectal neoplasia: a community-based evaluation of a potential diagnostic testS Wilson, S Damery, D D Stocken, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 4, 2000
A phase II study of the 5-lipoxygenase inhibitor, CV6504, in advanced pancreatic cancer: correlation of clinical data with pharmacokinetic and pharmacodynamic endpointsD R Ferry, M Deakin, J Baddeley, et al.
FEBS Letters|June 1, 1999
Differential association of cytoplasmic signalling molecules SHP-1, SHP-2, SHIP and phospholipase C-gamma1 with PECAM-1/CD31N J Pumphrey, V Taylor, S Freeman, et al.
Oncogene|November 21, 1996
CD40-induced growth inhibition in epithelial cells is mimicked by Epstein-Barr Virus-encoded LMP1: involvement of TRAF3 as a common mediatorA G Eliopoulos, C W Dawson, G Mosialos, et al.
Pageof 13

Showing results (121-130 of 129) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 129 results.
Advances in Enzyme Regulation|January 1, 1997
Role and regulation of phospholipase D activity in normal and cancer cellsM J Wakelam, A Martin, M N Hodgkin, et al.
Biochemical Society Transactions|November 1, 1993
Phosphatidylcholine hydrolysis: a source of multiple lipid messenger moleculesM J Wakelam, C P Briscoe, A Stewart, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1996
Antigen receptors on immature, but not mature, B and T cells are coupled to cytosolic phospholipase A2 activation: expression and activation of cytosolic phospholipase A2 correlate with lymphocyte maturationJ J Gilbert, A Stewart, C A Courtney, et al.
Advances in Second Messenger and Phosphoprotein Research|January 1, 1993
Phosphatidylcholine hydrolysis: a multiple messenger generating systemM J Wakelam, T R Pettitt, P Kaur, et al.
Biochimica Et Biophysica Acta|January 20, 1998
Inhibition of phospholipid signalling and proliferation of Swiss 3T3 cells by the wortmannin analogue demethoxyviridinM J Cross, M N Hodgkin, J A Plumb, et al.
British Journal of Cancer|March 22, 2012
Serum matrix metalloproteinase 9 and colorectal neoplasia: a community-based evaluation of a potential diagnostic testS Wilson, S Damery, D D Stocken, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 4, 2000
A phase II study of the 5-lipoxygenase inhibitor, CV6504, in advanced pancreatic cancer: correlation of clinical data with pharmacokinetic and pharmacodynamic endpointsD R Ferry, M Deakin, J Baddeley, et al.
FEBS Letters|June 1, 1999
Differential association of cytoplasmic signalling molecules SHP-1, SHP-2, SHIP and phospholipase C-gamma1 with PECAM-1/CD31N J Pumphrey, V Taylor, S Freeman, et al.
Oncogene|November 21, 1996
CD40-induced growth inhibition in epithelial cells is mimicked by Epstein-Barr Virus-encoded LMP1: involvement of TRAF3 as a common mediatorA G Eliopoulos, C W Dawson, G Mosialos, et al.
Pageof 13